Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang-Yu Liu

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
BMJ (Clinical Research Ed.)|October 23, 2024
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trialMin He, Yi-Zhou Jiang, Yue Gong, et al.
Breast Cancer Research and Treatment|April 25, 2012
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancerKe-Da Yu, Ying Zhou, Guang-Yu Liu, et al.
The Lancet. Oncology|January 11, 2024
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trialLei Fan, Zhong-Hua Wang, Lin-Xiaoxi Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
Cancer Cell|December 5, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrialLei Fan, Wen-Juan Zhang, Hui-Ping Li, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
BMJ (Clinical Research Ed.)|October 23, 2024
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trialMin He, Yi-Zhou Jiang, Yue Gong, et al.
Breast Cancer Research and Treatment|April 25, 2012
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancerKe-Da Yu, Ying Zhou, Guang-Yu Liu, et al.
The Lancet. Oncology|January 11, 2024
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trialLei Fan, Zhong-Hua Wang, Lin-Xiaoxi Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
Cancer Cell|December 5, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrialLei Fan, Wen-Juan Zhang, Hui-Ping Li, et al.
Pageof 12